The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
Abstract
Depression represents a major public health problem. It is estimated that 13-20% of the population has some depressive symptoms at any given time and about 5% of the population is assumed to suffer from major depression. Known pathological processes include ischemia, neoplasia, necrosis, apoptosis, infection, and inflammation. Of those, inflammation is the most compatible with the waxing and waning course of depression, and could explain the biology of this disorder that has a fluctuating course with severe episodes that can be followed by partial or complete remission. Over the years a body of evidence has been accumulated suggesting that major depression is associated with dysfunction of inflammatory mediators. Major depression commonly co-occurs with ischemic heart disease and decreased bone mineral density. Depressive symptoms are known to have a negative impact on cardiovascular prognosis, increasing the mortality rate of coronary artery disease. Several lines of evidence indicate that brain cytokines, principally interleukin-1beta (IL-1beta) and IL-1 receptor antagonist may have a role in the biology of major depression, and that they might additionally be involved in the pathophysiology and somatic consequences of depression as well as in the effects of antidepressant treatment. A particularly unique and novel aspect of the studies and views discussed here is their potential to lead to interventions which may reduce the morbidity and mortality risks for osteoporosis, c…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Immune system actions profoundly impact mood regulation.
“a growing recognition that immune system actions profoundly impact mood regulation (3–6)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [6]
Cites
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,593 · see citing works
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 3,380 · see citing works
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · see citing works
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559 · see citing works
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504 · see citing works
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · see citing works
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151 · see citing works
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122 · see citing works
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E. L., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088 · see citing works
cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877 · see citing works
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y. E., Collier, K. J., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816 · see citing works
Cytokines and the nervous system I: expression and recognition
Hopkins, S. J., & Rothwell, N. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80029-2 · Cited by 793 · see citing works
Gold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766 · see citing works
Interleukin-1 Immunoreactive Innervation of the Human Hypothalamus
Breder, C. D., Dinarello, C. A., & Saper, C. B. (1988) · Science · doi:10.1126/science.3258444 · Cited by 759 · see citing works
Release of Multiple Hormones by a Direct Action of Interleukin-1 on Pituitary Cells
Bernton, E. W., Beach, J. E., Holaday, J. W., Smallridge, R. C., & Fein, H. G. (1987) · Science · doi:10.1126/science.2821620 · Cited by 671 · see citing works
Depression and the Course of Coronary Artery Disease
Glassman, A. H., & Shapiro, P. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.4 · Cited by 671 · see citing works
A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
McMahan, C. J., Slack, J. L., Mosley, B., Cosman, D. J., Lupton, S., Brunton, L. L., Grubin, C. E., Wignall, J. M., Jenkins, N. A., & Brannan, C. I. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07831.x · Cited by 663 · see citing works
Prevention of Vertebrate Neuronal Death by the crmA Gene
Gagliardini, V., Fernandez, P.-A., Lee, R. K. K., Drexler, H. C. A., Rotello, R. J., Fishman, M. C., & Yuan, J. (1994) · Science · doi:10.1126/science.8303301 · Cited by 612 · see citing works
Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims
Nemeroff, C. B. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300075009 · Cited by 555 · see citing works
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
Relton, J. K., & Rothwell, N. J. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90033-t · Cited by 548 · see citing works
Layé, S., Parnet, P., Goujon, E., & Dantzer, R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90197-x · Cited by 500 · see citing works
Barone, F. C., White, R. F., Spera, P. A., Ellison, J. A., Currie, R. W., Wang, X., & Feuerstein, G. (1998) · Stroke · doi:10.1161/01.str.29.9.1937 · Cited by 485 · see citing works
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483 · see citing works
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 478 · see citing works
Amygdala core nuclei volumes are decreased in recurrent major depression
Sheline, Y. I., Gado, M. H., & Price, J. L. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00021 · Cited by 472 · see citing works
Ericsson, A., Liu, C., Hart, R. P., & Sawchenko, P. E. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903610410 · Cited by 471 · see citing works
Bone Mineral Density in Women with Depression
Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471 · see citing works
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
Gold, P., Chrousos, G., Kellner, C., Post, R., Roy, A., Augerinos, P., Schulte, H., Oldfield, E., & Loriaux, D. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 460 · see citing works
Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat
Nguyen, K. T., Deak, T., Owens, S. M., Kohno, T., Fleshner, M., Watkins, L. R., & Maier, S. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02239.1998 · Cited by 460 · see citing works
Abnormal Hypothalamic–Pituitary–Adrenal Function in Anorexia Nervosa
Gold, P. W., Gwirtsman, H. E., Avgerinos, P. C., Nieman, L. K., Gallucci, W. T., Kaye, W. H., Jimerson, D. C., Ebert, M. H., Rittmaster, R. S., Loriaux, D. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142102 · Cited by 455 · see citing works
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K. W., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 441 · see citing works
Indicators of immune activation in major depression
Sluzewska, A., RYBAKOWSKI, J. K., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M. H. J., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384 · see citing works
Quagliarello, V., Wispelwey, B., Long, W. J., & Scheld, W. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115140 · Cited by 372 · see citing works
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364 · see citing works
Leptin actions on food intake and body temperature are mediated by IL-1
Luheshi, G. N., Gardner, J. D., Rushforth, D. A., Loudon, A. S., & Rothwell, N. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7047 · Cited by 362 · see citing works
Holsboer, F., von Bardeleben, U., Gerken, A., Stalla, G. K., & Müller, O. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410253111718 · Cited by 348 · see citing works
Brady, L. S., Whitfield, H. J., Fox, R. J., Gold, P. W., & Herkenham, M. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115086 · Cited by 338 · see citing works
Cunningham, E. T., Wada, E., Carter, D., Tracey, D. E., Battey, J., & Souza, E. B. D. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01101.1992 · Cited by 334 · see citing works
Inducible nitric oxide synthase gene expression in the brain during systemic inflammation
Wong, M.-L., Rettori, V., AL-Shekhlee, A., Bongiorno, P. B., Canteros, G., McCann, S. M., Gold, P. W., & Licinio, J. (1996) · Nature Medicine · doi:10.1038/nm0596-581 · Cited by 286 · see citing works
Self-citationImmobilization stress induces interleukin-1β mRNA in the rat hypothalamus
Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y., & Satoh, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90944-o · Cited by 258 · see citing works
Souza, E. B. D., Whitehouse, P. J., Kuhar, M. J., Price, D. L., & Vale, W. (1986) · Nature · doi:10.1038/319593a0 · Cited by 255 · see citing works
Linthorst, A., Flachskamm, C., Müller-Preuss, P., Holsboer, F., & Reul, J. M. H. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-04-02920.1995 · Cited by 233 · see citing works
Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology
Rothwell, N. J., Luheshi, G., & Toulmond, S. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02033-0 · Cited by 233 · see citing works
Quan, N., Sundar, S. K., & Weiss, J. M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90188-0 · Cited by 230 · see citing works
Parnet, P., Garka, K. E., Bonnert, T. P., Dower, S., & Sims, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.3967 · Cited by 223 · see citing works
Wong, M., Bongiorno, P. B., Rettori, V., McCann, S. M., & Licinio, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.227 · Cited by 222 · see citing works
Self-citationPathways and mechanisms for cytokine signaling of the central nervous system.
Licinio, J., & Wong, M. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119846 · Cited by 220 · see citing works
Self-citationConnor, T., Song, C., Leonard, B. E., Merali, Z., & Anisman, H. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00533-2 · Cited by 195 · see citing works
Localization of type I interleukin-1 receptor mRNA in the rat brain
Yabuuchi, K., Minami, M., Katsumata, S., & Satoh, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90180-5 · Cited by 186 · see citing works
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174 · see citing works
Purification and characterization of a novel soluble receptor for interleukin 1.
Symons, J. A., Eastgate, J., & Duff, G. W. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.5.1251 · Cited by 171 · see citing works
Kakucska, I., Qi, Y., Clark, B. D., & Lechan, R. M. (1993) · Endocrinology · doi:10.1210/endo.133.2.8344218 · Cited by 161 · see citing works
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally
Bluthe, R.-M., Michaud, B., Kelley, K. W., & Dantzer, R. (1996) · NeuroReport · doi:10.1097/00001756-199606170-00008 · Cited by 158 · see citing works
Regulation of the Human Serotonin Transporter by Interleukin-1β
Ramamoorthy, S., Ramamoorthy, J. D., Prasad, P. D., Bhat, G. K., Mahesh, V. B., Leibach, F. H., & Ganapathy, V. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2659 · Cited by 156 · see citing works
The nitric oxide hypothesis of aging
McCann, S. M., Licinio, J., Wong, M., Yu, W. H., Karanth, S., & Rettori, V. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00050-3 · Cited by 151 · see citing works
Self-citationGabellec, M., Griffais, R., Fillion, G., & Haour, F. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00042-q · Cited by 145 · see citing works
Endogenous Interleukin-1 Receptor Antagonist is Neuroprotective
Loddick, S. A., Wong, M., Bongiorno, P. B., Gold, P. W., Licinio, J., & Rothwell, N. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6436 · Cited by 140 · see citing works
Self-citationHippocampal atrophy in major depression: a result of depression-induced neurotoxicity?
Sheline, Y. I. (1996) · PubMed · Cited by 137 · see citing works
Scammell, T. E., Griffin, J. D., Elmquist, J. K., & Saper, C. B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r783 · Cited by 130 · see citing works
Brain iNOS: current understanding and clinical implications
Licinio, J., Prolo, P., McCann, S. M., & Wong, M. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01453-7 · Cited by 120 · see citing works
Self-citationLocalization of Interleukin 1 Type I Receptor mRNA in Rat Brain
Wong, M., & Licinio, J. (2006) · NeuroImmunoModulation · doi:10.1159/000097143 · Cited by 118 · see citing works
Self-citationLocalization of Interleukin-1 Receptor Antagonist mRNA in Rat Brain
Licinio, J., Wong, M., & Gold, P. W. (1991) · Endocrinology · doi:10.1210/endo-129-1-562 · Cited by 106 · see citing works
Self-citationInhibition of nitric oxide synthase produces hypothermia and depresses lipopolysaccharide fever
Scammell, T. E., Elmquist, J. K., & Saper, C. B. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.2.r333 · Cited by 102 · see citing works
Strijbos, P. J. L. M., Relton, J. K., & Rothwell, N. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91485-0 · Cited by 87 · see citing works
Colotta, F., Re, F., Muzio, M., Polentarutti, N., Minty, A. J., Caput, D., Ferrara, P., & Mantovani, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99886-8 · Cited by 86 · see citing works
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats
Bluthé, R.-M., Beaudu, C., Kelley, K. W., & Dantzer, R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00194-u · Cited by 82 · see citing works
Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor α in mice
Bluthé, R.-M., Dantzer, R., & Kelley, K. W. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90184-r · Cited by 79 · see citing works
Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2)
Lovenberg, T. W., Crowe, P. D., Liu, C., Chalmers, D. T., Liu, X.-J., Liaw, C. W., Clevenger, W., Oltersdorf, T., Souza, E. B. D., & Maki, R. A. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00047-1 · Cited by 79 · see citing works
Increased Expression of Tumor Necrosis Factor-α Receptors in the Brains of Patients With AIDS
Sippy, B. D., Hofman, F. M., Wallach, D., & Hinton, D. R. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199510050-00004 · Cited by 79 · see citing works
Behavioral and neural influences on cellular immune responses: effects of stress and interleukin-1.
Weiss, J. M., Sundar, S. K., Becker, K. J., & Cierpial, M. A. (1989) · PubMed · Cited by 78 · see citing works
Gold, P., Wong, M., Chrousos, G. P., & Licinio, J. (1996) · PubMed · Cited by 77 · see citing works
Self-citationCorticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury
Lyons, M., Anderson, R. E., & Meyer, F. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)91310-w · Cited by 71 · see citing works
IL-1β, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas
Wong, M., Bongiorno, P. B., Alshekhlee, A., Esposito, A. A., Khatri, P., & Licinio, J. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00008 · Cited by 70 · see citing works
Self-citationRomero, L. I., Kakucska, I., Lechan, R. M., & Reichlin, S. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.3.r518 · Cited by 59 · see citing works
Romero, L. I., Tatro, J. B., Field, J. A., & Reichlin, S. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.2.r326 · Cited by 59 · see citing works
Liu, C., Chalmers, D. T., Maki, R. A., & Souza, E. B. D. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00016-1 · Cited by 59 · see citing works
Mechanisms of the Behavioral Effects of Interleukin 1 Role of Prostaglandins and CRFa
Bluthé, R.-M., Crestani, F., KELLEY, K. W., & Dantzer, R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb49135.x · Cited by 58 · see citing works
Suzuki, E., Shintani, F., Kanba, S., Asai, M., & Nakaki, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12985-2 · Cited by 55 · see citing works
Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala
Wong, M., Loddick, S. A., Bongiorno, P. B., Gold, P. W., Rothwell, N. J., & Licinio, J. (1995) · Neuroreport · doi:10.1097/00001756-199509000-00019 · Cited by 52 · see citing works
Self-citationWong, M., Bongiorno, P. B., Gold, P. W., & Licinio, J. (1995) · NeuroImmunoModulation · doi:10.1159/000096884 · Cited by 47 · see citing works
Self-citationCytokine interactions and cytokine balance in the brain: relevance to neurology and psychiatry
Plata‐Saláman, C. R., & Turrin, N. P. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000528 · Cited by 42 · see citing works
Widespread Activation and Consequences of Interleukin-1 in the Brain
Weiss, J. M., Quan, N., & Sundar, S. K. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb23117.x · Cited by 34 · see citing works
Modulation of the behavioural effects of Interleukin-1 in mice by Nitric Oxide
Bluthé, R., Sparber, S. B., & Dantzer, R. (1992) · Neuroreport · doi:10.1097/00001756-199202000-00022 · Cited by 30 · see citing works
Erratum: Cytokines in affective disorders and schizophrenia: new clinical and genetic findings
Prolo, P., & Licinio, J. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000555 · Cited by 21 · see citing works
Self-citationPlata‐Saláman, C. R., & Turrin, N. P. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000527 · Cited by 15 · see citing works
Takao, T., Tojo, C., Nishioka, T., Makino, S., Hashimoto, K., & Souza, E. B. D. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00398-0 · Cited by 8 · see citing works
Raju, T. N. K. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60383-2 · Cited by 6 · see citing works
INTERLEUKIN-1: EFFECTS IN THE CENTRAL NERVOUS SYSTEM AND RELEVANCE TO AIDS
Weiss, J. M., & Sundar, S. K. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00342 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774 · see citing works
Stress and the inflammatory response: A review of neurogenic inflammation
Black, P. H. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00021-1 · Cited by 687 · see citing works
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656 · see citing works
Self-citationMajor depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586 · see citing works
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568 · see citing works
Self-citationEpidemiology of comorbid coronary artery disease and depression
Rudisch, B. E., & Nemeroff, C. B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00587-0 · Cited by 549 · see citing works
Cytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459 · see citing works
Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology
Fennell, C. W., Lindsey, K. L., McGaw, L. J., Sparg, S. G., Stafford, G. I., Elgorashi, E. E., Grace, O. M., & van Staden, J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.05.012 · Cited by 457 · see citing works
Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421 · see citing works
Kuo, H., Yen, C., Chang, C., Kuo, C.-K., Chen, J.-H., & Sorond, F. A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 400 · see citing works
Role of Interleukin-6 in Depressive Disorder
Ting, E. Y.-C., Yang, A. C., & Tsai, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 391 · see citing works
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A.-M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 376 · see citing works
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370 · see citing works
Dayan, J., Creveuil, C., Marks, M. N., Conroy, S., Herlicoviez, M., Dreyfus, M., & Tordjman, S. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000244025.20549.bd · Cited by 356 · see citing works
Neuroplasticity and cellular resilience in mood disorders
Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 339 · see citing works
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315 · see citing works
Depression and Other Mental Health Diagnoses Increase Mortality Risk After Ischemic Stroke
Williams, L. S., Ghose, S. S., & Swindle, R. W. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1090 · Cited by 309 · see citing works
Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression
Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 307 · see citing works
Depression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298 · see citing works
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299 · see citing works
Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 301 · see citing works
Depression in patients with chronic renal disease
Kimmel, P. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00310-0 · Cited by 297 · see citing works
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295 · see citing works
Self-citationAntidepressant activity of aqueous extracts of Curcuma longa in mice
Yu, Z. F., Kong, L., & Chen, Y. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00211-8 · Cited by 293 · see citing works
Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltagirone, C., & Robinson, R. G. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001879 · Cited by 293 · see citing works
Kunz-Ebrecht, S., Mohamed‐Ali, V., Feldman, P. J., Kirschbaum, C., & Steptoe, A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00029-1 · Cited by 290 · see citing works
Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · see citing works
Inflammatory T helper 17 cells promote depression-like behavior in mice
Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254 · see citing works
Inflammation in Children and Adolescents With Neuropsychiatric Disorders: A Systematic Review
Mitchell, R. H. B., & Goldstein, B. I. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.013 · Cited by 241 · see citing works
The Molecular Neurobiology of Depression
Shelton, R. C. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.005 · Cited by 242 · see citing works
Plasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder
Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., Chrousos, G. P., & Geracioti Jr., T. D. (2001) · Neuroimmunomodulation · doi:10.1159/000049028 · Cited by 238 · see citing works
Bechter, K., Reiber, H., Herzog, S., Fuchs, D., Tumani, H., & Maxeiner, H. G. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.008 · Cited by 230 · see citing works
Anti-inflammatory properties of desipramine and fluoxetine
Roumestan, C., Michel, A., Bichon, F., Portet, K., Detoc, M., Henriquet, C., Jaffuel, D., & Mathieu, M. N. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-35 · Cited by 229 · see citing works
Screening, Diagnosis, and Treatment of Depression in Patients with End-Stage Renal Disease
Cohen, S. D., Norris, L., Acquaviva, K., Peterson, R. A., & Kimmel, P. L. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03951106 · Cited by 229 · see citing works
Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems
Gądek-Michalska, A., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71527-5 · Cited by 225 · see citing works
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225 · see citing works
Self-citationSocial factors and individual vulnerability to chronic stress exposure
Bartolomucci, A., Palanza, P., Sacerdote, P., Panerai, A. E., Sgoifo, A., Dantzer, R., & Parmigiani, S. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.06.009 · Cited by 225 · see citing works
Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224 · see citing works
Self-citationBasso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224 · see citing works
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · see citing works
Hao, Z., Wang, W., Guo, R., & Liu, H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.025 · Cited by 242 · see citing works
Serotonin Regulates Osteoclast Differentiation Through Its Transporter
Battaglino, R. A., Fu, J., Späte, U., Ersoy, U., Joe, M., Sedaghat, L., & Stashenko, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040606 · Cited by 215 · see citing works
Depression and anxiety and outcomes of coronary artery bypass surgery
Pignay-Demaria, V., Lespérance, F., Demaria, R., Frasure‐Smith, N., & Perrault, L. P. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04391-6 · Cited by 214 · see citing works
Depressive disorders—is it time to endorse different pathophysiologies?
Antonijevic, I. A. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.004 · Cited by 207 · see citing works
Neuropsychiatric Disease and Toxoplasma gondii Infection
Henriquez, S., Brett, R. R., Alexander, J. K., Pratt, J. A., & Roberts, C. W. (2009) · NeuroImmunoModulation · doi:10.1159/000180267 · Cited by 208 · see citing works
Antioxidative enzymes and increased oxidative stress in depressive women
Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197 · see citing works
Th2 Cytokine Response in Major Depressive Disorder Patients before Treatment
Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187 · see citing works
Kunz, M., Ceresér, K. M. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000300010 · Cited by 189 · see citing works
Cytokine and growth factor involvement in schizophrenia—support for the developmental model
Nawa, H., Takahashi, M., & Patterson, P. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000730 · Cited by 189 · see citing works
Chesnokova, V., & Melmed, S. K. (2002) · Endocrinology · doi:10.1210/endo.143.5.8861 · Cited by 188 · see citing works
Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180 · see citing works
Pharmacogenetics of antidepressant response
Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 179 · see citing works
Monje, F. J., Cabatic, M., Divisch, I., Kim, E.-J., Herkner, K. R., Binder, B. R., & Pollak, D. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1537-11.2011 · Cited by 178 · see citing works
Cytokines, stress, and depressive illness
Anisman, H., & Merali, Z. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00009-0 · Cited by 225 · see citing works
Nawa, H., & Takei, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.002 · Cited by 174 · see citing works
Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer
Sephton, S. E., Dhabhar, F. S., Keuroghlian, A. S., Giese-Davis, J., McEwen, B. S., Ionan, A. C., & Spiegel, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.007 · Cited by 170 · see citing works
Licinio, J., O'Kirwan, F., Irizarry, K. J. L., Merriman, B., Thakur, S., Jepson, R., Lake, S. L., Tantisira, K. G., Weiss, S. T., & Wong, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168 · see citing works
Self-citationDepression: a major, unrecognized risk factor for osteoporosis?
Cizza, G., Ravn, P., Chrousos, G. P., & Gold, P. W. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00407-6 · Cited by 168 · see citing works
Kéri, S., Szabó, C., & Kelemen, O. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.03.020 · Cited by 165 · see citing works
Okusaga, O., Yolken, R. H., Langenberg, P., Lapidus, M., Arling, T. A., Dickerson, F. B., Scrandis, D. A., Severance, E., Cabassa, J. A., Balis, T., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.029 · Cited by 163 · see citing works
Depression in End-Stage Renal Disease Patients: A Critical Review
Kimmel, P. L., Cukor, D., Cohen, S. D., & Peterson, R. A. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2007.07.007 · Cited by 164 · see citing works
De La Garza, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.016 · Cited by 153 · see citing works
Yu, Y. W. ‐., Chen, T., Hong, C., Chen, H.-M., & Tsai, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300172 · Cited by 150 · see citing works
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150 · see citing works
Futamura, T., Toyooka, K., Iritani, S., Niizato, K., Nakamura, R., Tsuchiya, K., Someya, T., Kakita, A., Takahashi, H., & Nawa, H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001081 · Cited by 146 · see citing works
Updating the mild encephalitis hypothesis of schizophrenia
Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 141 · see citing works
Davidson, K. W., Burg, M. M., Kronish, I. M., Shimbo, D., Dettenborn, L., Mehran, R., Vorchheimer, D. A., Clemow, L., Schwartz, J. E., & Rieckmann, N. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.36 · Cited by 138 · see citing works
Depression and osteoporosis: epidemiology and potential mediating pathways
Mezuk, B., Eaton, W. W., & Golden, S. H. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0449-2 · Cited by 134 · see citing works
Brain-immune interactions and disease susceptibility
Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 132 · see citing works
Nutrition, Inflammation, and Cognitive Function
Wärnberǵ, J., Gómez‐Martínez, S., Romeo, J., Díaz, L. E., & Marcos, A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03985.x · Cited by 131 · see citing works
Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression
Varghese, A. K., Verdu, E. F., Berčík, P., Khan, W. I., Blennerhassett, P. A., Szechtman, H., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.007 · Cited by 128 · see citing works
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Duda, P., Wiśniewski, J., Wójtowicz, T., Wójcicka, O., Jaskiewicz, M. R., Drulis‐Fajdasz, D., Rakus, D., McCubrey, J. A., & Gizak, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1526925 · Cited by 121 · see citing works
Distinguishing fatigue and depression in patients with cancer.
Jacobsen, P. B., Donovan, K. A., & Weitzner, M. A. (2003) · PubMed · doi:10.1016/s1084-3612(03)00049-2 · Cited by 122 · see citing works
Green tea consumption is associated with depressive symptoms in the elderly
Niu, K., Hozawa, A., Kuriyama, S., Ebihara, S., Guo, H., Nakaya, N., Ohmori‐Matsuda, K., Takahashi, H., Masamune, Y., Asada, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28216 · Cited by 118 · see citing works
Cytokines and the aging brain – what we don't know might help us
Bodles, A. M., & Barger, S. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.07.011 · Cited by 120 · see citing works
Loftis, J. M., Huckans, M. S., Ruimy, S., Hinrichs, D. J., & Hauser, P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.001 · Cited by 117 · see citing works
Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis
Yirmiya, R., & Bab, I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.016 · Cited by 114 · see citing works
Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes
Anisman, H., Kokkinidis, L., & Merali, Z. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00011-9 · Cited by 112 · see citing works
Allopregnanolone as a mediator of affective switching in reproductive mood disorders
Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3599-x · Cited by 107 · see citing works
Anti-TNF-α Compounds as a Treatment for Depression
Uzzan, S., & Azab, A. N. (2021) · Molecules · doi:10.3390/molecules26082368 · Cited by 109 · see citing works
Brunello, N., Alboni, S., Capone, G., Benatti, C., Blom, J. M. C., Tascedda, F., Kriwin, P., & Mendlewicz, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00004 · Cited by 104 · see citing works
Dubey, N., Hoffman, J. F., Schuebel, K., Yuan, Q., Martinez, P. E., Nieman, L. K., Rubinow, D. R., Schmidt, P. J., & Goldman, D. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.229 · Cited by 103 · see citing works
The role of the cytokine network in psychological stress
Kim, Y., & Maes, M. H. J. (2003) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2003.00026.x · Cited by 103 · see citing works
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
Steenblock, C., Todorov, V., Kanczkowski, W., Eisenhofer, G., Schedl, A., Wong, M., Licinio, J., Bauer, M., Young, A. H., Gainetdinov, R. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0758-9 · Cited by 102 · see citing works
Self-citationStreit (2005) · doi:10.1179/016164105x49463 · Cited by 100 · see citing works
Regulatory role of the cannabinoid CB2receptor in stress‐induced neuroinflammation in mice
Zoppi, S., Madrigal, J. L. M., Caso, J. R., García‐Gutiérrez, M. S., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12607 · Cited by 99 · see citing works
Wong, S. Y. S., Lau, E. M. C., Lynn, H., Leung, P., Woo, J., Cummings, S., & ORWOLL, E. S. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1730-2 · Cited by 98 · see citing works
The Association between Conventional Antidepressants and the Metabolic Syndrome
McIntyre, R. S., Park, K. Y., Law, C. W. Y., Sultan, F., Adams, A., Lourenço, M. T. C., Lo, A., Soczynska, J. K., Woldeyohannes, H. O., Alsuwaidan, M. T., et al. (2010) · CNS Drugs · doi:10.2165/11533280-000000000-00000 · Cited by 96 · see citing works
Inserra, A., Mastronardi, C. A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 95 · see citing works
Self-citationREVIEW: Biological risk factors for late life depression
Tiemeier, H. W. (2003) · European Journal of Epidemiology · doi:10.1023/a:1025388203548 · Cited by 95 · see citing works
Depression and Stroke: Cause or Consequence?
Williams, L. S. (2005) · Seminars in Neurology · doi:10.1055/s-2005-923534 · Cited by 95 · see citing works
Chronic psychosocial stress down-regulates central cytokines mRNA
Bartolomucci, A., Palanza, P., Parmigiani, S., Pederzani, T., Merlot, É., Neveu, P. J., & Dantzer, R. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.009 · Cited by 94 · see citing works
Maxwell, M. A., & Cole, D. A. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.007 · Cited by 95 · see citing works
Nishitani, N., Nagayasu, K., Asaoka, N., Yamashiro, M., Andoh, C., Nagai, Y., Kinoshita, H., Kawai, H., Shibui, N., Liu, B., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0254-y · Cited by 92 · see citing works
Kagaya, A., Kugaya, A., Takebayashi, M., Fukue, M., Saeki, T., Yamawaki, S., & Uchitomi, Y. (2001) · Neuropsychobiology · doi:10.1159/000054867 · Cited by 92 · see citing works
A multi‐component assessment model for monitoring training distress among athletes
Main, L. C., & Grove, B. (2009) · European Journal of Sport Science · doi:10.1080/17461390902818260 · Cited by 90 · see citing works
Wu, H., Tang, X.-Q., Mao, X.-F., & Wang, Y. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-17.2017 · Cited by 87 · see citing works
Role of IL-1 in Poststroke Depressive-like Behavior in Mice
Craft, T. K. S., & DeVries, A. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.011 · Cited by 87 · see citing works
Su, S., Miller, A. H., Snieder, H., Bremner, J. D., Ritchie, J., Maisano, C., Jones, L. R., Murrah, N. V., Goldberg, J. H., & Vaccarino, V. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819082ef · Cited by 87 · see citing works
- Authors
- Licinio, J., & Wong, M.-L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Licinio, J
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 1999-07-01
- Volume
- 4
- Issue
- 4
- Pages
- 317-327
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2103997793
- Cited by
- 380
- References
- 88
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 6 · 2020: 13 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 11 · 2012: 17
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, IL-1β, interleukin-1 receptor antagonist, neuroinflammation, neuroprotection, neurotoxicity, antidepressant treatment, cardiovascular risk, bone mineral density, osteoporosis
- MeSH terms
- Animals, Brain, Depressive Disorder, Humans, Inflammation, Neurotoxins, Stress, Psychological, Cytokines, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review